This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of potential therapeutic agents. It serves as a key intermediate in the creation of compounds that target neurological and psychiatric disorders, such as anxiety and depression, due to its structural similarity to molecules that interact with neurotransmitter receptors. Additionally, it is explored for its potential role in modulating serotonin and dopamine pathways, making it valuable in the study of central nervous system disorders. Its nitro and phenylpiperazine groups contribute to its biological activity, enabling researchers to design and test novel drugs with improved efficacy and selectivity.